Table 2.
Features of hepatocellular carcinoma at the time of diagnosis and treatments used during follow-up
| Mean (SD)/Number | |
|---|---|
| Barcelona clinic liver cancer | |
| Stage 0 | 7 |
| Stage A | 30 |
| Stage B | 21 |
| Stage C | 34 |
| Stage D | 6 |
| Okuda | |
| Stage 1 | 51 |
| Stage 2 | 40 |
| Stage 3 | 7 |
| Number of lesions | 4 (1–15) |
| Diameter of biggest lesion | 2.5 (0.73) |
| TACE | 24 |
| TARE | 10 |
| RFA | 25 |
| Resection | 53 |
| Transplantation | 2 |
| Chemotherapy | 20 |
RFA: Radiofrequency ablation; TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization.